The US health regulator has pulled up drug major Sun Pharmaceutical Limited for manufacturing lapses which include failure to follow the appropriate written procedures which are designed to prevent microbiological

Sun Pharmaceutical Industries Limited, announced that one of its wholly-owned subsidiaries launched a novel anti-cancer drug in India, Palbociclib. This drug is for patients who have advanced breast cancer, the